CSDAP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.373000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.220800E-01
Normal-vs-Stage2
7.536200E-01
Normal-vs-Stage3
8.296400E-01
Normal-vs-Stage4
4.091800E-01
Stage1-vs-Stage2
4.502000E-01
Stage1-vs-Stage3
9.885800E-01
Stage1-vs-Stage4
1.598590E-01
Stage2-vs-Stage3
5.279800E-01
Stage2-vs-Stage4
2.280400E-01
Stage3-vs-Stage4
2.226400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.203800E-01
Normal-vs-AfricanAmerican
5.948800E-01
Normal-vs-Asian
7.509600E-01
Caucasian-vs-AfricanAmerican
7.094000E-01
Caucasian-vs-Asian
2.926000E-01
AfricanAmerican-vs-Asian
2.603000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.790200E-01
Normal-vs-Female
7.948600E-01
Male-vs-Female
5.689800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.928000E-01
Normal-vs-Age(41-60Yrs)
5.371400E-01
Normal-vs-Age(61-80Yrs)
8.765800E-01
Normal-vs-Age(81-100Yrs)
7.234000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.966240E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.733800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.439000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.063200E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.491800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.853750E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.123400E-01
Normal-vs-Daily Drinker
6.625000E-01
Normal-vs-Weekly Drinker
7.259800E-01
Normal-vs-Occasional Drinker
6.768200E-01
Normal-vs-Social Drinker
6.704600E-01
Non Drinker-vs-Daily Drinker
2.623800E-01
Non Drinker-vs-Weekly Drinker
6.091000E-01
Non Drinker-vs-Occasional Drinker
4.258200E-01
Non Drinker-vs-Social Drinker
4.071000E-01
Daily Drinker-vs-Weekly Drinker
1.322030E-01
Daily Drinker-vs-Occasional Drinker
1.326780E-01
Daily Drinker-vs-Social Drinker
1.961790E-01
Weekly Drinker-vs-Occasional Drinker
7.365800E-01
Weekly Drinker-vs-Social Drinker
5.930200E-01
Occasional Drinker-vs-Social Drinker
7.826600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.967200E-01
Normal-vs-Grade 2
2.421000E-01
Normal-vs-Grade 3
2.482400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.898400E-02
Grade 1-vs-Grade 3
3.140900E-03
Grade 1-vs-Grade 4
5.967200E-01
Grade 2-vs-Grade 3
5.128300E-02
Grade 2-vs-Grade 4
2.421000E-01
Grade 3-vs-Grade 4
2.482400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.425200E-01
Normal-vs-NonDiabetic
8.384800E-01
Diabetic-vs-NonDiabetic
5.407600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.124000E-01
Normal-vs-NoPancreatitis
9.107800E-01
Pancreatitis-vs-NoPancreatitis
3.457600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.802400E-01
Normal-vs-N1
7.310800E-01
N0-vs-N1
4.230400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.409400E-01
Normal-vs-TP53-NonMutant
9.522200E-01
TP53-Mutant-vs-TP53-NonMutant
1.375760E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
